Navigation Links
Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
Date:2/6/2008

ts and Services Segment

In the Laboratory Products and Services Segment, revenues grew 10% in the fourth quarter of 2007 to $1.55 billion, compared with pro forma 2006 revenues of $1.40 billion. Operating income increased 19% in the fourth quarter of 2007, and operating margin rose to 13.4%, versus pro forma 2006 results of 12.4%.

For the full year, pro forma segment revenues grew 7% to $5.84 billion in 2007, compared with $5.44 billion in 2006. Pro forma adjusted operating income for the segment grew 20% in 2007, and pro forma adjusted operating margin increased to 13.6%, versus 12.2% a year ago.

Use of Non-GAAP Financial Measures

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-GAAP financial measures, including adjusted EPS, adjusted operating income and adjusted operating margin, which exclude restructuring and other costs/income and amortization of acquisition-related intangible assets. Adjusted EPS also excludes certain other gains and losses, tax provisions/benefits related to the previous items, benefits from tax credit carryforwards, the impact of significant tax audits or events and discontinued operations. We exclude the above items because they are outside of our normal operations and/or, in certain cases, are difficult to forecast accurately for future periods. We believe that the use of non-GAAP measures helps investors to gain a better understanding of our core operating results and future prospects, consistent with how management measures and forecasts the company's performance, especially when comparing such results to previous periods or forecasts.

For example:

We exclude costs and tax effects associated with restructuring activities, such as reducing overhead and consolidating facilities in connection with the Fisher merger and our Kendro acquisition. We believe that the costs related to these restructuring activities are
'/>"/>

SOURCE Thermo Fisher Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related biology technology :

1. Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
2. ThermoGenesis Corp. to Announce Second Quarter Fiscal 2008 Results on February 6, 2008
3. Thermo Fisher Scientific to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference
4. Thermo Fisher Scientific to Present at the 26th Annual JPMorgan Healthcare Conference
5. Thermo Fisher Scientific Acquires Leading Chromatography Consumables Provider, La-Pha-Pack
6. Thermo Fisher Scientific Selected by China Doping Control Center to Supply Testing Instrumentation for the 2008 Olympic Games in Beijing
7. MIT: Thermoelectric materials are 1 key to energy savings
8. ThermoGenesis Corp. to Announce First Quarter Fiscal 2008 Results on November 8, 2007
9. Thermo Fisher Scientific Reports Record Third Quarter Revenues and Adjusted EPS and Raises Full-Year Guidance
10. Thermo Fisher Scientific to Expand Manufacturing Operation for Single-Use Bioprocessing Containers
11. Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...swire-FirstCall/ -- Dendreon Corporation (Nasdaq: ...g Administration (FDA) provided written acknowledg... Application (BLA) for PROVENGE® (sipuleucel-... Prescription Drug User Fee Act (PDUFA) date of Ma...on,s amended BLA. Dendreon is seeking licensure f...
(Date:11/20/2009)...OLEDO recently announced that a free webinar, &ldq...t-Line Particle Characterization”, will be p...e application of in situ particle characterization...ize a series of roller compaction runs while varyi...n forces. , (PRWEB) Novem...
(Date:11/19/2009)...wire-FirstCall/ -- Omeros Corporation (Nasdaq: OM...or the third quarter ended September 30, 2009. For... reported a net loss of $3.9 million, or $1.34 per... or $2.54 per share, for the same period in 2008. ...Company reported a net loss of $15.5 million, or $...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- Spherix Incorporated (Nas...abetes therapy, and a provider of technical and re...biotechnology and pharmaceutical companies, today ...of Shareholders. ,, At the meeting, shareholder... the following members to the Board of Directors: ...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4
...uly 1 BioMarin,Pharmaceutical Inc. (Nasdaq and SW...h.D., Chief Medical Officer of BioMarin, will pres... Conference in New York City on,Wednesday, July 9,...cess a live audio webcast of the presentation,via ...p://www.BMRN.com . A,replay of the presentation wi...
... Ben Eynon Each Assume Vice President Roles at ...N, Texas, July 1 Molecular Imprints, Inc., the,ma...ms and solutions, today,announced that Ben Eynon a...These distinguished industry veterans are assuming...ness development for semiconductors, and,vice pres...
...lized Psychiatric Patient Evaluation for Clinical ...ug Development, HAMILTON, N.J., July 1 MedAvante...ent evaluation, announced today that it has,closed...nd Trevi Health,Ventures. MedAvante has developed ... the assessment of patients undergoing treatment i...
Other Biology Technology:BioMarin to Present at the Collins Stewart Growth Conference 2Industry Veterans Join Molecular Imprints' Management Team 2Industry Veterans Join Molecular Imprints' Management Team 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 2MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 3MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures 4
(Date:11/22/2009)...have succeeded in producing the polymers used for ...han through the use of fossil fuel based chemicals...w for the production of environmentally conscious ...l Biotechnology and Bioengineering to mark the j...ules found in everyday life in the form of plastic...
(Date:11/22/2009)...terfly,s proboscis looks like a straw -- long, sle...ke a paper towel, according to Konstantin Kornev o...s of this piece of insect anatomy to make small pr... Kornev will present his work next week at the 62...,s (APS) Division of Fluid Dynamics will take plac...
(Date:11/21/2009)...ewswire / - KINAXO Biotechnologies GmbH announce... new investors in the company, Leifina and Conmit ... Schumacher has been elected as a new member of th... Axel Ullrich, Hellmut Kirchner, Manfred Ferber as...tain Partners, BioM, High-Tech Grnderfonds, the Ma...
Breaking Biology News(10 mins):Bioengineers succeed in producing plastic without the use of fossil fuels 2KINAXO Completes Financing Round to Enhance Biomarker Development 2KINAXO Completes Financing Round to Enhance Biomarker Development 3WHO Withdraws Notice of Concern for Mylans Matrix Unit 13730 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 1NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 2NTU and Temasek Foundation transfer technology knowhow to Chinas quake prone regions 9723 3Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 1Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 2Kristi Yamaguchi Olympic Ice Skater Pushes Seasonal Flu Shots 55601 3
...DGE, Mass.-MIT scientists have found a way to indu...t could one day serve as tiny engineered blood ves...ol the cells, development by growing them on a sur...rk was posted this month in an online issue of Adv...d one day be transplanted into tissues such as the...
...ON, Ill. --- Neurotransmitters have consequences. ...y life, giving us the ability to move, to talk, to...ters are getting it right and sending proper signa...lls. , Now a Northwestern University study repor...controls a neurotransmitter in the nematode C. ele...
...ILLE, Tenn. U.S. Courts have decreed that the fe...naging nuclear wastes that will ensure the safety ...s, a period that is 200 times the length of record...rtainty in Long-Term Planning Nuclear Waste Manag...om government, industry, academia and the environm...
Other Biology News:MIT works toward engineered blood vessels 2Overexcited neurons not good for cell health 2Overexcited neurons not good for cell health 3Managing nuclear wastes for the millennia 2
VACUGENE PUMP 110V from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-DLK1 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Cryopreservation Service from AbD Serotec
...mismatch repair minus strains of E. coli. Use of t...zed unmethylated strand (1), leading to high mutat...ystems as the GeneEditor and Altered Sites II Muta...e recA+, therefore inserts containing highly repet...
Biology Products: